BOA could be great exposure to SIR. They share the NE border and have an MC 1/5th the size of MAT (doesn't mean much as MAT has other great projects that BOA doesn't but still interesting).
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
